LOS ANGELES–(BUSINESS WIRE)–A securities class action lawsuit has been filed against Tenax Therapeutics, Inc. (“Tenax” or the “Company”) (NASDAQ: TENX) on behalf of investors who purchased or otherwise acquired Tenax Therapeutics, Inc. securities from November 13, 2023 to August 7, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Katz v. Tenax Therapeutics, Inc. et al., filed on October 26, 2026 in the U.S. District Court North Carolina Middle District (Case No. 1:26-